In addition to the Director and Deputy Director, the senior leadership of DF/HCC includes nine Associate Directors and thirteen Deputy Associate Directors (some of whom serve in more than one role). The Associate Directors have oversight and coordination responsibility for: Basic Science, Clinical Science, Population Science, Core Facilities, Planning and Evaluation, Development, Membership, and Administration. The Deputy Associate Director assists the respective Associate Director in his/her duties and is available to assume these duties should the Associate Director be unable to serve. These senior leaders meet every other week as the DF/HCC Executive Committee (EC), whose functions are described in Section 6.0 Organizational Capabilities. Six of these individuals also serve as Institutional Representatives. Dr. Fred Alt is the Institutional Representative for Children's Hospital Boston but does not currently serve as an Associate Director or Deputy Associate Director for the DF/HCC. Dr. Alt does participate as a member of the Executive Committee. Since the seven independent institutions participating in DF/HCC have different cultures as well as different locations, the primary responsibility of the Institutional Representative is for communication. In particular, they insure that the DF/HCC members within their institutions are aware of all activities, policies and procedures of the Cancer Center, and that the Center leadership is made aware of any issues from their institution. In addition, they are responsible for the day-to-day representation of the interests of DF/HCC at their institution, and the interests of their institution within DF/HCC. (Members of the Governance Committee have the ultimate responsibility for such institutional interests.)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006516-46
Application #
8038406
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-12-01
Budget End
2010-11-30
Support Year
46
Fiscal Year
2010
Total Cost
$570,294
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Mills, Evanna L; Pierce, Kerry A; Jedrychowski, Mark P et al. (2018) Accumulation of succinate controls activation of adipose tissue thermogenesis. Nature 560:102-106
Oser, Matthew G; Fonseca, Raquel; Chakraborty, Abhishek A et al. (2018) Cells Lacking the RB1 Tumor Suppressor Gene are Hyperdependent on Aurora B Kinase for Survival. Cancer Discov :
Choudhury, Atish D; Gray, Kathryn P; Supko, Jeffrey G et al. (2018) A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer. Prostate :
Watson, Noreen L; Mull, Kristin E; Heffner, Jaimee L et al. (2018) Participant Recruitment and Retention in Remote eHealth Intervention Trials: Methods and Lessons Learned From a Large Randomized Controlled Trial of Two Web-Based Smoking Interventions. J Med Internet Res 20:e10351
Pednekar, M S; Nagler, E M; Gupta, P C et al. (2018) Scaling up a tobacco control intervention in low resource settings: a case example for school teachers in India. Health Educ Res 33:218-231
Braun, Danielle; Yang, Jiabei; Griffin, Molly et al. (2018) A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations. J Genet Couns 27:1187-1199
Santana-Codina, Naiara; Roeth, Anjali A; Zhang, Yi et al. (2018) Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nat Commun 9:4945
Cox, Andrew G; Tsomides, Allison; Yimlamai, Dean et al. (2018) Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth. EMBO J 37:
Oxnard, Geoffrey R; Hu, Yuebi; Mileham, Kathryn F et al. (2018) Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib. JAMA Oncol 4:1527-1534
Patil, Prasad; Parmigiani, Giovanni (2018) Training replicable predictors in multiple studies. Proc Natl Acad Sci U S A 115:2578-2583

Showing the most recent 10 out of 411 publications